Shogo Yamamoto

31.6k citations
196 papers · 7.9k indexed · 1 hit paper · h-index 47
Topics
Inflammatory mediators and NSAID effects (26 papers)Eicosanoids and Hypertension Pharmacology (18 papers)Estrogen and related hormone effects (12 papers)
Partner nations
JapanUnited StatesCanada

In The Last Decade

Shogo Yamamoto

188 papers receiving 7.7k citations

Hit Papers

Purification of prostaglandin endoperoxide synthetase fro...19762026199220091976100200300400500

Peers

Shogo Yamamoto
Comparison fields: 5 of 149
  • Molecular Biology 4.0k
  • Pharmacology 1.9k
  • Biochemistry 1.1k
  • Genetics 968
  • Cancer Research 917
Replace Chieko Yokoyama with:
Chieko Yokoyama Japan
Scott D. Hauser United States
Hiroyasu Inoue Japan
Pamela T. Manning United States
K. Leahy United States
Xiao-Ming Yin United States
Joohun Ha South Korea
Friedrich Marks Germany
Gerhard Fürstenberger Germany
Roberta A. Gottlieb United States
Shogo Yamamoto relative to Chieko Yokoyama Japan Chieko Yokoyama's profile →
Citations per field
00.5×3.0×
Chieko Yokoyama · 1×
Citations per year

Countries citing papers authored by Shogo Yamamoto

Since Specialization
Citations

This map shows the geographic impact of Shogo Yamamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shogo Yamamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shogo Yamamoto more than expected).

Fields of papers citing papers by Shogo Yamamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shogo Yamamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shogo Yamamoto. The network helps show where Shogo Yamamoto may publish in the future.

Co-authorship network of co-authors of Shogo Yamamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Shogo Yamamoto. A scholar is included among the top collaborators of Shogo Yamamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shogo Yamamoto. Shogo Yamamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 2
4 151
5 22
6 77
7 26
8 25
9 49
10 23
11 83
12 70
13 15
14 3
15
A hydrolase enzyme inactivating endogenous ligands for cannabinoid receptors.
20
16
Transcriptional regulation of fatty acid cyclooxygenases-1 and -2.
16
17 10
18 70
19 11
20 17

About Shogo Yamamoto

Shogo Yamamoto is a scholar working on Biochemistry, Pharmacology and Toxicology, having authored 196 papers that have together received 7.9k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (26 papers), Eicosanoids and Hypertension Pharmacology (18 papers) and Estrogen and related hormone effects (12 papers). The work is most often cited by research in Biochemistry (1.1k citations), Pharmacology (1.9k citations) and Cancer Research (917 citations). Shogo Yamamoto has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Osamu Hayaishi, N Ogino, Hiroyuki Aburatani, Natsuo Ueda, Tsumoru Miyamoto, T Yoshimoto, S. Ohki, Masayuki Inui, Yutaka Midorikawa and Hideaki Yukawa. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026